CA2211448A1 - Antigenes de rejet de tumeurs de la famille rage - Google Patents

Antigenes de rejet de tumeurs de la famille rage

Info

Publication number
CA2211448A1
CA2211448A1 CA002211448A CA2211448A CA2211448A1 CA 2211448 A1 CA2211448 A1 CA 2211448A1 CA 002211448 A CA002211448 A CA 002211448A CA 2211448 A CA2211448 A CA 2211448A CA 2211448 A1 CA2211448 A1 CA 2211448A1
Authority
CA
Canada
Prior art keywords
seq
nucleic acid
rage
pro
tumor rejection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002211448A
Other languages
English (en)
Inventor
Beatrice Gaugler
Benoit Van Den Eynde
Peter Schrier
Nathalie Brouwenstijn
Thierry Boon-Falleur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ludwig Institute for Cancer Research Ltd
Universiteit Leiden
Original Assignee
Ludwig Institute For Cancer Research
Beatrice Gaugler
Benoit Van Den Eynde
Peter Schrier
Nathalie Brouwenstijn
Thierry Boon-Falleur
Leiden University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/530,569 external-priority patent/US5939526A/en
Application filed by Ludwig Institute For Cancer Research, Beatrice Gaugler, Benoit Van Den Eynde, Peter Schrier, Nathalie Brouwenstijn, Thierry Boon-Falleur, Leiden University filed Critical Ludwig Institute For Cancer Research
Publication of CA2211448A1 publication Critical patent/CA2211448A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA002211448A 1995-03-21 1996-03-21 Antigenes de rejet de tumeurs de la famille rage Abandoned CA2211448A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US40801595A 1995-03-21 1995-03-21
US08/408,015 1995-03-21
US08/530,569 1995-09-20
US08/530,569 US5939526A (en) 1995-03-21 1995-09-20 Isolated RAGE-1 derived peptides which complex with HLA-B7 molecules and uses thereof

Publications (1)

Publication Number Publication Date
CA2211448A1 true CA2211448A1 (fr) 1996-09-26

Family

ID=27020105

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002211448A Abandoned CA2211448A1 (fr) 1995-03-21 1996-03-21 Antigenes de rejet de tumeurs de la famille rage

Country Status (6)

Country Link
EP (1) EP0815229A2 (fr)
JP (1) JPH11506904A (fr)
AU (1) AU705768B2 (fr)
CA (1) CA2211448A1 (fr)
NZ (1) NZ306122A (fr)
WO (1) WO1996029409A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7284598A (en) * 1997-05-05 1998-11-27 Incyte Pharmaceuticals, Inc. Rage1-like protein
WO1999004265A2 (fr) * 1997-07-17 1999-01-28 Ludwig Institute For Cancer Research Acides nucleiques et polypeptides associes au cancer
AU3900399A (en) * 1998-05-13 1999-11-29 Ludwig Institute For Cancer Research Tumor associated antigen encoded by the reverse strand of a new ubiquitously expressed gene
US6686147B1 (en) * 1998-07-15 2004-02-03 Ludwig Institute For Cancer Research Cancer associated antigens and uses therefor
CN1367830A (zh) * 1998-10-05 2002-09-04 路德维哥癌症研究院 癌症相关抗原及其应用
WO2000020586A2 (fr) * 1998-10-05 2000-04-13 Ludwig Institute For Cancer Research Antigenes associes au cancer du rein et leurs utilisations
WO2006113540A2 (fr) 2005-04-14 2006-10-26 Duke University Utilisation d'un agent qui restaure l'irrigation et l'oxygenation des tissus
US20110311448A1 (en) * 2007-11-02 2011-12-22 Ann Marie Schmidt Antibody to rage and uses for in vivo imaging or for targeting therapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994005304A1 (fr) * 1992-08-31 1994-03-17 Ludwig Institute For Cancer Research Nonapeptide isole derive du gene mage-3 et presente par hla-a1, et ses utilisations

Also Published As

Publication number Publication date
EP0815229A2 (fr) 1998-01-07
WO1996029409A3 (fr) 1996-11-07
JPH11506904A (ja) 1999-06-22
AU705768B2 (en) 1999-06-03
WO1996029409A2 (fr) 1996-09-26
NZ306122A (en) 1999-06-29
AU5429896A (en) 1996-10-08

Similar Documents

Publication Publication Date Title
US6803448B1 (en) GBS toxin receptor
US5965535A (en) Mage-3 peptides presented by HLA class II molecules
JP3096739B2 (ja) Ｈｌａ分子によって提示される単離ノナペプチドとその使用
US5939526A (en) Isolated RAGE-1 derived peptides which complex with HLA-B7 molecules and uses thereof
US20030165981A1 (en) Polypeptide, cDNA encoding the same, and use of them
CA2231746A1 (fr) Transporteur de phosphate dependant du sodium humain (ipt-1)
WO2000009692A1 (fr) Peptides capables de modulation en cas de cardiopathie inflammatoire
US20080227110A1 (en) Human Genes, Sequences and Expression Products
US6013481A (en) Isolated, nucleic acid molecules which code for gage tumor rejection antigen, the tumor rejection antigen, and uses thereof
CA2211448A1 (fr) Antigenes de rejet de tumeurs de la famille rage
EP0804467A1 (fr) Molecules d'acide nucleique isoles et tronques codant pour l'antigene gage de rejet des tumeurs
WO1998040397A1 (fr) Proteines inhibitrices de bax
CA2217450A1 (fr) Utilisation d'une lymphokine pour inhiber la replication de virus et, en particulier, de retrovirus, provoquant une immunodeficience
WO1999046293A1 (fr) Proteine a doigt de zinc derivee de cellules hematopoietiques
JPH10150993A (ja) 新規ｇ−蛋白結合受容体ｈｌｔｅｘ１１
JP4813720B2 (ja) ヒト循環ウイルス阻害ペプチド（ｖｉｒｉｐ）及びその使用
US6984622B2 (en) Use of lipopolysaccharides to manage corneal infections and wounds
EP0452433A1 (fr) Proteins inhibant la cytolyse (cti) et sequences adn codant pour lesdites proteines
CA2333466C (fr) Recepteur de la toxine gbs
AU713364B2 (en) Transforming growth factor alpha HII
JPH10337189A (ja) 新規化合物
AU727028B2 (en) Brain glycogen phosphorylase cancer antigen
CA2249213A1 (fr) Proteine extracellulaire/epidermique de type facteur de croissance
KR19980703534A (ko) 사람 크립틴 성장 인자
KR20040002917A (ko) 바이러스 복제를 억제하는 방법

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead